Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $16,106 | 2 | 40.6% |
| Unspecified | $9,685 | 8 | 24.4% |
| Travel and Lodging | $7,127 | 31 | 18.0% |
| Food and Beverage | $4,370 | 142 | 11.0% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1,745 | 2 | 4.4% |
| Education | $623.52 | 3 | 1.6% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Ferring Pharmaceuticals Inc. | $26,155 | 86 | $0 (2024) |
| Allergan Inc. | $9,805 | 11 | $0 (2018) |
| PFIZER INC. | $942.15 | 2 | $0 (2024) |
| Myovant Sciences Inc. | $913.85 | 3 | $0 (2022) |
| ABBVIE INC. | $669.37 | 25 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $263.29 | 17 | $0 (2020) |
| EMD Serono, Inc. | $251.24 | 14 | $0 (2024) |
| Covidien LP | $117.33 | 5 | $0 (2020) |
| Organon LLC | $109.50 | 5 | $0 (2022) |
| CONMED Corporation | $62.50 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $217.82 | 6 | ABBVIE INC. ($93.28) |
| 2023 | $120.28 | 5 | Ferring Pharmaceuticals Inc. ($72.07) |
| 2022 | $14,561 | 43 | Ferring Pharmaceuticals Inc. ($14,174) |
| 2021 | $3,803 | 32 | Ferring Pharmaceuticals Inc. ($1,775) |
| 2020 | $1,260 | 15 | Ferring Pharmaceuticals Inc. ($1,152) |
| 2019 | $428.19 | 19 | AbbVie, Inc. ($93.64) |
| 2018 | $9,725 | 43 | Ferring Pharmaceuticals Inc. ($8,863) |
| 2017 | $9,542 | 25 | Allergan Inc. ($9,315) |
All Payment Transactions
188 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/13/2024 | Ferring Pharmaceuticals Inc. | MENOPUR (Biological) | Food and Beverage | In-kind items and services | $29.61 | General |
| Category: REPRODUCTIVE HEALTH | ||||||
| 06/20/2024 | Ferring Pharmaceuticals Inc. | MENOPUR (Biological) | Food and Beverage | In-kind items and services | $34.34 | General |
| Category: REPRODUCTIVE HEALTH | ||||||
| 06/11/2024 | PFIZER INC. | PREMARIN (Drug), DUAVEE, MYFEMBREE | Food and Beverage | In-kind items and services | $17.15 | General |
| Category: WOMENS HEALTH | ||||||
| 05/02/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $16.87 | General |
| 03/21/2024 | Ferring Pharmaceuticals Inc. | MENOPUR (Biological) | Food and Beverage | In-kind items and services | $26.57 | General |
| Category: REPRODUCTIVE HEALTH | ||||||
| 03/15/2024 | ABBVIE INC. | ORILISSA (Drug) | Food and Beverage | In-kind items and services | $93.28 | General |
| Category: WOMENS HEALTH | ||||||
| 11/09/2023 | Ferring Pharmaceuticals Inc. | MENOPUR (Drug) | Food and Beverage | In-kind items and services | $15.04 | General |
| Category: REPRODUCTIVE HEALTH | ||||||
| 10/12/2023 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $27.27 | General |
| 09/14/2023 | Ferring Pharmaceuticals Inc. | MENOPUR (Drug) | Food and Beverage | In-kind items and services | $32.76 | General |
| Category: REPRODUCTIVE HEALTH | ||||||
| 07/26/2023 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $20.94 | General |
| 07/08/2023 | Ferring Pharmaceuticals Inc. | MENOPUR (Drug) | Food and Beverage | In-kind items and services | $24.27 | General |
| Category: REPRODUCTIVE HEALTH | ||||||
| 10/26/2022 | Myovant Sciences Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $77.89 | General |
| Category: HORMONE THERAPY | ||||||
| 10/25/2022 | Myovant Sciences GmbH | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $49.44 | General |
| Category: HORMONE THERAPY | ||||||
| 10/19/2022 | Hologic, LLC | FLUENT FLUID MANAGEMENT SYSTEM (Device) | Food and Beverage | In-kind items and services | $31.28 | General |
| Category: Surgical | ||||||
| 10/15/2022 | Ferring Pharmaceuticals Inc. | — | Travel and Lodging | In-kind items and services | $168.98 | General |
| 10/15/2022 | Ferring Pharmaceuticals Inc. | — | Travel and Lodging | In-kind items and services | $105.03 | General |
| 10/15/2022 | Ferring Pharmaceuticals Inc. | — | Food and Beverage | In-kind items and services | $60.00 | General |
| 10/15/2022 | Ferring Pharmaceuticals Inc. | — | Food and Beverage | In-kind items and services | $50.00 | General |
| 10/15/2022 | Ferring Pharmaceuticals Inc. | — | Food and Beverage | In-kind items and services | $40.00 | General |
| 10/15/2022 | Ferring Pharmaceuticals Inc. | — | Food and Beverage | In-kind items and services | $30.00 | General |
| 10/15/2022 | Ferring Pharmaceuticals Inc. | — | Food and Beverage | In-kind items and services | $30.00 | General |
| 10/15/2022 | Ferring Pharmaceuticals Inc. | — | Food and Beverage | In-kind items and services | $4.79 | General |
| 10/14/2022 | Ferring Pharmaceuticals Inc. | — | Travel and Lodging | In-kind items and services | $456.97 | General |
| 10/14/2022 | Ferring Pharmaceuticals Inc. | — | Travel and Lodging | In-kind items and services | $290.75 | General |
| 10/14/2022 | Ferring Pharmaceuticals Inc. | — | Food and Beverage | In-kind items and services | $122.09 | General |
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A PROSPECTIVE NON-INTERVENTIONAL OBSERVATIONAL REGISTRY OF US UTERINE FIBROID PATIENTS | Allergan Inc. | $5,620 | 5 |
| A RANDOMIZED, PLACEBO-CONTROLLED, PARALLEL GROUP, MULTICENTER STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ULIPRISTAL ACETATE FOR THE INTERMITTENT TREATMENT OF ABNORMAL UTERINE BLEEDING ASSOCIATED WITH LEIOMYOMAS | Allergan Inc. | $4,065 | 3 |
About Dr. Vicky Schnell, M.D
Dr. Vicky Schnell, M.D is a Reproductive Endocrinology healthcare provider based in Webster, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/20/2005. The National Provider Identifier (NPI) number assigned to this provider is 1669458881.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Vicky Schnell, M.D has received a total of $39,658 in payments from pharmaceutical and medical device companies, with $217.82 received in 2024. These payments were reported across 188 transactions from 21 companies. The most common payment nature is "Consulting Fee" ($16,106).
Practice Information
- Specialty Reproductive Endocrinology
- Location Webster, TX
- Active Since 12/20/2005
- Last Updated 04/17/2008
- Taxonomy Code 207VE0102X
- Entity Type Individual
- NPI Number 1669458881
Products in Payments
- MENOPUR (Drug) $15,679
- MYFEMBREE (Drug) $963.29
- FOLLISTIM AQ (Biological) $246.41
- Lupron (Drug) $232.61
- ORILISSA (Drug) $203.75
- TruClear (Device) $117.33
- Gonal-f (Biological) $103.41
- Orilissa (Drug) $93.64
- MENOPUR (Biological) $90.52
- ORIAHNN (Drug) $75.96
- AIRSEAL (Device) $62.50
- SEPRAFILM (Device) $46.25
- LO LOESTRIN FE (Drug) $42.13
- CERVIDIL (Drug) $33.69
- Acessa (Drug) $31.30
- FLUENT FLUID MANAGEMENT SYSTEM (Device) $31.28
- PREGNYL (Drug) $29.90
- Prenate Mini (Drug) $24.77
- Vitafol Ultra (Drug) $20.85
- SYMPHION (Device) $17.47
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.